TREMFYA
NDC 57894-650, Guselkumab, injection, from Janssen Biotech, Inc..
- Product NDC
- 57894-650
- Status
- Listed
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761061
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57894-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUSELKUMAB200 mg/20mL
Pharmacologic classes
Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57894-650-02 | 57894065002 | 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-650-02) / 20 mL in 1 VIAL, SINGLE-DOSE (57894-650-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=57894-650
Use it
Look up 57894-650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57894-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57894-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.